Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcellx (ACLX) Research & Development (2023 - 2025)

Arcellx has reported Research & Development over the past 3 years, most recently at $34.1 million for Q4 2025.

  • For Q4 2025, Research & Development fell 23.64% year-over-year to $34.1 million; the TTM value through Dec 2025 reached $157.6 million, changed 0.33%, while the annual FY2025 figure was $157.6 million, 0.33% changed from the prior year.
  • Research & Development for Q4 2025 was $34.1 million at Arcellx, down from $35.1 million in the prior quarter.
  • Over five years, Research & Development peaked at $50.8 million in Q1 2025 and troughed at $28.3 million in Q2 2023.
  • A 3-year average of $37.4 million and a median of $36.4 million in 2025 define the central range for Research & Development.
  • On a YoY basis, Research & Development climbed as much as 57.19% in 2025 and fell as far as 23.64% in 2025.
  • Year by year, Research & Development stood at $28.8 million in 2023, then surged by 55.12% to $44.6 million in 2024, then dropped by 23.64% to $34.1 million in 2025.
  • Business Quant data shows Research & Development for ACLX at $34.1 million in Q4 2025, $35.1 million in Q3 2025, and $37.6 million in Q2 2025.